INTRODUCTION
Hypersensitivity pneumonitis (HP) is a group of lung diseases that result from repeated pulmonary exposure to a variety of environmental organic dusts, fungi, and molds with uncertain immunological mechanisms (1) . This disorder affects the parenchyma and the small airways of the lungs and presents an acute, subacute or chronic form. Consequently, HP may lead to irreversible pulmonary damages, which cause fibrosis or emphysema, and depend on several factors such as duration of exposure and nature of the inhaled antigens (2) .
Although the pathogenesis of HP is incompletely understood, it has been generally accepted that a combination of humoral and cell-mediated immune responses contributes to the development of HP (3) . Several studies have suggested that the murine models of experimental HP are mediated by Th1 immune responses. In mice, adoptive transfer of Th1 clones increased cell infiltration and caused reversible HP (4) . Moreover, when the Th1/Th2 balance shifts toward Th1 immune responses, the HP is more severe whereas it is attenuated by Th2-biased responses (5, 6) . Beside T cells, various immune cell types including neutrophils, lymphocytes, monocytes, and macrophages have been known to be involved in the development of HP (7) . Upon antigen challenge, a large number of alveolar macrophages infiltrate the lungs and secrete cytokines and chemokines such as TNF-α, IL-1, IL-8, and MIP-1α, which recruit neutrophils and lymphocytes (8, 9) . Chemokine-induced infiltration of neutrophils is found in the alveoli and followed by an influx of activated T cells with a predominance of CD8 ＋ T cells (8) . In Saccharopolyspora rectivirgula (SR)-induced HP of murine models, neutrophils are most prominent in bronchoalveolar lavage fluid (BALF) immediately after antigen challenge, and they produce a large amount of IFN-γ (10) . Moreover, we previously demonstrated that NKT cells suppress IFN-γ-producing Gr-1 ＋ granulocytes by producing IL-4, resulting in the attenuation of SR-induced HP (11) . These observations suggest that macrophages, neutrophils and NKT cells may play an important role in development of HP.
Fcγ receptors (FcγRs) for IgG are surface glycoproteins and bridge humoral and cellular immunity by directing the interaction of antibodies with effector cells. These receptors are expressed on effector cells of the immune system and mediate phagocytosis, antibody-dependent cell-mediated cytotoxicity (ADCC), and activation of inflammatory cells (12, 13) . To date, four different classes of FcγRs (FcγRI, FcγRIIB, FcγRIII and FcγRIV) have been recognized in mice (14, 15) . FcγRIIB provides inhibitory signals, whereas FcγRI, Fc γRIII, and FcγRIV act as activating receptors in immune cells (16) . In mice, monocytes and macrophages express all activating and inhibitory FcγRs (FcγRI-FcγRIV), while neutrophils express the inhibitory FcγRIIB and the activating Fc γRIII and FcγRIV. In addition, the expression of FcγRI, FcγRIIB, and FcγRIII dominates on dendritic cell (DC)s (17) . In rodents, cell surface expression and signaling capacity of all activating FcγRs (FcγRI, FcγRIII, and Fcγ RIV) are dependent on the γ-chain. Therefore, genetic deletion of this subunit leads to loss of cell surface expression of FcγRs, resulting in functional deficiency of these activating FcγRs. Therefore, γ-chain of Fc receptor-knockout animals showed dramatically impaired antibody mediated effector cell responses (14, (18) (19) (20) (21) .
During HP, immune complexes formed by soluble antigens and IgG antibodies trigger the complement cascade, resulting in activation of alveolar macrophage, in sequence, recruitment of neutrophils and lymphocytes (2) . Furthermore, prominent humoral responses have been reported in pigeon fancier's disease, one of the most common HP in human (22) , as revealed by the elevated levels of IgGs in BALF and the infiltration of B lymphocytes into interstitial and alveolar spaces (23, 24) . Based on these observations, we postulate that immune complexes of exposed antigens and IgGs activate neutrophils and macrophages via FcγRs, which may contribute to initiation of pulmonary inflammation upon SR antigen challenge. Therefore, in this study, we investigated the functional roles of FcγRs in the development of murine SR-induced HP using Fcγ-chain knockout mice. C shaking incubator for 4 days, centrifuged, and rinsed with PBS three times. Next, SR antigen was homogenized and lyophilized. The SR antigen was re-suspended in pyrogen-free saline. SR antigen contained less than 20 ng/mg endotoxin, estimated using a limulus amebocyte lysate assay (Sigma Chemical, St. Louis, MO).
MATERIALS AND METHODS

Mice
The induction of HP and histological examination of the lungs HP was induced by intranasal administration of 150μg SR antigen in saline into mice under light anesthesia using isoflurane. The procedure was performed on three consecutive days in each week for three weeks. To evaluate histological alteration of the lungs, paraffin sections of the lungs fixed in formalin were cut and stained with hematoxylin and eosin. Pathologic scores were defined as follows: 0, no lung abnormality; 1∼5, the presence of inflammation and granulomas involving 10, 10∼30, 30∼50, 50∼80, and ＞80% of the lungs, respectively.
Bronchoalveolar lavage and FACS analysis
To preparation BALF from mice, tracheas were cannulated and lungs were lavaged five times with 1ml of cold PBS. Each sample was then centrifuged at 2,000 rpm for 10 min at The total number of cells was counted by a hemacytometer, and the samples were incubated with mAbs for 5 min on ice to block FcγRII/III. Without washing, these cells were stained in a 200μl total volume with a 1μg combination of the following mAbs: anti-CD8, CD4, TCR, B220, F4/80, NK1.1, CD11c, CD11b, and Gr-1 mAbs. These mAbs were purchased from BD bioscience (SanDiego, CA) or Ebioscience (San diego, CA). Data were acquired by FACS Calibar (Becton Dickinson, San Jose, CA, USA).
ELISA for measurement of SR-specific IgGs
Diluted serum (1：10) was added to ELISA high-binding plates (Greiner, USA Scientific, Inc., Ocala, FL) coated with SR (500μg/ml) antigen in PBS (pH 7.4) and incubated overnight at 4 o C. Next, alkaline phosphatase-conjugated goat anti-mouse IgG (Pierce, Rockford, IL) diluted in PBS/0.1% bovine serum albumin (BSA) (1：5,000) was added and the plates were incubated for 1 h at room temperature. The plates were then washed and 100μl of phosphatase substrate (ρ-nitrophenyl-phosphate in a carbonate buffer, pH 9.6) was added to each well. The absorbance of each sample was read at 405 nm using a BioTek ELx808 microplate reader and Gen5 software package (BioTek Instruments Inc., Winooski, VT).
SR-specific proliferation assay
The spleen cells were taken from B6 and FcγR −/− mice administered SR antigen for 3 weeks and cultured with filtered SR antigen. SR-specific immune cell proliferation was determined using MTS assay kits (Promega, Madison, WI).
Real-time polymerase chain reaction (PCR)
For quantitative real-time PCR, whole lungs were homogenized and the total lung mRNA extracts was prepared using an RNeasy Mini Kit (Qiagen Korea Ltd., Seoul, Korea (Fig. 1C) .
However, the percentage of CD8 ＋ T cells among gated lymphocytes in BALF of FcγR −/− mice was similar to that of B6 mice in SR-induced HP, whereas the percentage of CD4 ＋ T cells was much higher than that of B6 mice (Fig. 1D) . Therefore, CD8：CD4 T cell ratio was reduced in BALF of FcγR −/− mice compared to B6 mice during SR-induced HP.
Combined, these findings suggested that FcγR-deficeint innate immune cells such as neutrophils and macrophages less migrated into the lungs than those cells of B6 mice, whereas more T and B cells were recruited into the lungs of FcγR bronchial lymphocytic infiltration, alveolitis, interstitial fibrosis in B6 mice ( Fig. 2A) . In particular, the infiltration of neutrophils and macrophages in alveolar spaces and interstitium of B6 mice was prominent compared with FcγR −/− mice.
In contrast, peribronchial hyperplasia of lymphoid follicles was more frequently found in FcγR −/− mice than in B6 mice. Consistent with histological alteration in these mice, the histological scorings of the pulmonary lesions revealed significant attenuation of HP in FcγR −/− mice compared with B6 mice (Fig. 2B) .
FcγR-deficient mice show the reduced expression of chemokines and IFN-γ compared to B6 mice during SR-induced hypersensitivity pneumonitis
Many studies have indicated that various cytokines and chemokines are important in the pathogenesis of inflammatory lung diseases (8, 10, 26, 27) . Cytokines and chemokines induced by administration of SR antigen mediate the recruitment of immune cells and induce differentiation of Th1 cells, resulting in granuloma formation. To evaluate cytokines and chemokines expression in FcγR −/− and B6 mice after SR an- tigen administration, we measured mRNAs of IFN-γ, IL-4, IP-10, Mip1α, RANTES, and MCP-1 in the lungs. The expression of IP-10, Mip1α, RANTES, and MCP-1 was reduced in FcγR −/− mice compared to B6 mice (Fig. 3A) . Among these chemokines, the production of IP-10 was significantly different between B6 and FcγR −/− mice. Upon inoculation of SR-antigen, FcγR −/− mice exhibited the low levels of IFN-γ, whereas the transcript level of IL-4 was significantly increased (Fig. 3B) . Therefore, FcγR −/− mice show decreased chemokines expression and Th2-dominant immune responses during SR-induced HP.
FcγR-deficient mice do not affect SR-induced adaptive immune responses
The immunologic responses to SR antigen in SR-induced HP can be assessed by measuring SR-specific immune cell proliferation, and IgG levels in sera and BALF of mice given SR antigen (2, 28, 29) . To evaluate the immune responses against SR antigen, BALF and sera from B6 and FcγR −/− mice administered SR antigen three weeks after the first antigen exposure were obtained. FcγR −/− mice given SR antigen showed slightly higher serum SR-specific IgG levels (Fig. 4A) , whereas B6 mice challenged with SR antigen showed slightly higher IgG production in BALF (Fig. 4B) . However, we could not find statistically significant difference in the IgG levels both of sera and of BALF between B6 and FcγR −/− mice.
To evaluate SR-specific immune cell proliferation, splenocytes from B6 and FcγR −/− mice were stimulated with SR antigen in vitro 24 h. The proliferation of immune cells against SR antigen showed no difference between SR-challenged B6 and FcγR −/− mice (Fig. 4C) . These results indicated that activating FcγRs do not play a critical role in modulation of SR-induced adaptive immune responses.
DISCUSSION
During the development of HP, the inhaled antigen enters the alveolar spaces, crosses the alveolar endothelium, and binds to circulating antibody leading to immune complexes deposition within the lung (30 nism usually initiates and mediates the acute HP, while the latter mediates the subacute and chronic HP. Therefore, it is more likely that FcγR-mediated activation and recruitment of innate immune cells might be an early event of HP rather than occur at chronic phase of disease. IFN-γ produced by T cells and neutrophils in the lungs contributes to the development of murine HP, categorized as a Th1 disease (5, 33) . Moreover, IFN-γ-producing neutrophils contribute to granuloma formation in the absence of IFN-γ -producing T cells during SR-induced HP (10) . These findings indicate that innate immune cells more contribute to IFN-γ production and development of HP than adaptive immune cells do. In our experiments, the subset analysis of BALF revealed that neutrophils were remarkably reduced in BALF of Avoidance of the causative antigens and steroid treatment are well-known treatment of patients with HP. However, some patients develop advanced pulmonary fibrosis despite of treatment (2) . Therefore, alternative therapeutic modalities must be developed. Here, we propose a therapeutic approach using blockage of activating FcγRs based on our current research (11) . However, it is likely that the blockage of FcγRs might attenuate the protective function of FcγRIII-expressing NKT cells on HP, which provides adverse effects on the treatment of HP. Therefore, a comprehensive approach should be considered to optimize therapeutic effects on HP. In summary, our results demonstrate that activating signals through Fcγ receptors play an important role in the development of HP by provoking innate immune cells to mobilize and to produce cytokines in particular Th1 inducing cytokines. These results provide new insights into the complex immunological mechanisms underlying HP, and lead to the development of more effective therapeutic approaches for HP.
